A Simple Trick to Improve Our Transradial Punctures

Transradial access is here to stay; that much has been clear for some time now. However, some operators still resist change and the systematic use of this technique shows great geographical dispersion. Some of its limitations are a difficulty to obtain access and the somewhat frequent occurrence of radial artery occlusion after the procedure. This study assessed a very simple resource to avoid artery occlusion: an injection of nitroglycerin at the puncture site.

Un truco sencillo para mejorar nuestras punciones radialesThis work included 188 patients undergoing transradial catheterization who were randomized to subcutaneous injection of 0.5 mL 0.1% nitroglycerin at the puncture site or a placebo. All patients were assessed through ultrasound examinations before and at 24 hours after the procedure.

 

Upon comparison of the radial artery diameter before and after the procedure, patients in the nitroglycerin-treated group presented a significantly greater diameter than patients in the placebo control group. Most importantly, the incidence of occlusion was substantially lower in the nitroglycerin-treated group (5.4% vs. 14.4%; p = 0.04).


Read also: Antiaggregation Time after Treating Bifurcations.


There were no significant differences in other complications (forearm hematoma, pseudoaneurysm, etc.).

 

Conclusion

Subcutaneous injection of nitroglycerin at the radial artery puncture site increases the radial artery diameter and reduces the incidence of radial artery occlusion post-catheterization.

 

Original title: Subcutaneous Injection of Nitroglycerin at the Radial Artery Puncture Site Reduces the Risk of Early Radial Artery Occlusion After Transradial Coronary Catheterization. A Randomized, Placebo-Controlled Clinical Trial.

Reference: Yequn Chen et al. Circ Cardiovasc Interv. 2018;11:e006571.

 

2018-08-31-NTG-subcutánea-full


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....